Mechanisms of granulocyte homeostasis
粒细胞稳态机制
基本信息
- 批准号:9263013
- 负责人:
- 金额:$ 39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-07-01 至 2019-04-30
- 项目状态:已结题
- 来源:
- 关键词:AllelesBioinformaticsBiologicalBiologyBone MarrowCellsCessation of lifeClinicalComplementComplexDNA Sequence AlterationDataDysmyelopoietic SyndromesExtravasationFailureFeedbackFoundationsGene Expression ProfileGenesGeneticGenetic TranscriptionGranulopoiesisGrowth FactorHalf-LifeHematopoieticHeterogeneityHomeostasisHumanIFN consensus sequence binding proteinImmuneIndividualInfectionInvestigationKnowledgeMarrowMediatingMinorityModernizationMolecularMusMutationMyelogenousMyeloproliferative diseaseNeonatalNeutropeniaNeutrophiliaPatientsPatternPhenotypeProcessProductionRepressionRiskSamplingStressSumTimeTissuesTranscriptional RegulationWorkcytokineexperimental studygain of functiongenome sequencinggranulocytegut microbiomein vivoinsightloss of functionmanmonocytemouse modelneutrophilprogenitorprogramspublic health relevancesingle cell analysistranscription factortranscriptometranscriptome sequencing
项目摘要
DESCRIPTION (provided by applicant): Understanding granulocyte homeostasis is crucial because producing too few granulocytes results in increased risk for infection (neutropenia), while producing too many granulocytes can result in severe tissue damage and death (neutrophilia, myeloproliferative disorders). Current knowledge illustrates many factors that can modify granulocyte versus monocyte production; however, we still do not understand a fundamental question: which specific factors control the granulocyte-monocyte lineage decision during homeostatic production in vivo? To discern the transcriptional network underlying the binary fate decision between neutrophil granulocyte and monocyte lineage decisions as they occur at steady state (homeostatic control), we have performed single-cell RNA-seq on bone-marrow granulocyte-monocyte progenitors (GMP). Our bioinformatic analyses reveal a varied, but coherent spectrum of gene expression patterns in individual murine GMPs. The majority of cells could be clustered into ones expressing either granulocytic or monocytic genes, suggesting that they were primed for lineage determination. A minority of GMPs expressed a mixed-lineage pattern of genes. Deeper analyses of the single-cell data implicate the repression of a key requisite factor for monopoiesis in mice and man (Irf8) by a key requisite factor for granulopoiesis in mice and man (Gfi1) as the central mechanism for homeostatic control of the granulocyte-monocyte lineage decision in vivo. We propose to determine the transcriptional program underlying granulocyte-monocyte lineage fate decisions during homeostasis, and then define the impact of severe congenital neutropenia (SCN)-associated mutations on transcriptional control of granulopoiesis in mice and man. We expect to delineate a cross-species transcriptional signature of granulopoiesis, and define the impact of neutropenic stress.
描述(由申请人提供):了解粒细胞稳态至关重要,因为产生太少的粒细胞会导致感染风险增加(中性粒细胞减少症),而产生太多的粒细胞会导致严重的组织损伤和死亡(中性粒细胞增多症、骨髓增殖性疾病)。许多因素可以改变粒细胞与单核细胞的产生;然而,我们仍然不明白一个基本问题:哪些特定因素控制稳态产生过程中的粒细胞-单核细胞谱系决定。为了辨别中性粒细胞和单核细胞谱系决定在稳态(稳态控制)下发生的二元命运决定背后的转录网络,我们对骨髓粒细胞-单核细胞祖细胞进行了单细胞 RNA 测序(GMP)我们的生物信息学分析揭示了个体小鼠 GMP 中各种但一致的基因表达模式,大多数细胞可以聚集成表达粒细胞或单核细胞的细胞。基因,表明少数 GMP 表达了基因的混合谱系模式。小鼠和人类粒细胞生成的关键必要因子(Gfi1)作为体内粒细胞-单核细胞谱系决定的稳态控制的中心机制我们建议确定转录。细胞稳态过程中粒细胞-单核细胞谱系命运决定的基础程序,然后定义严重先天性中性粒细胞减少症(SCN)相关突变对小鼠和人类粒细胞生成转录控制的影响,以及我们期望描绘粒细胞生成的跨物种转录特征。定义中性粒细胞减少应激的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
H. LEIGHTON GRIMES其他文献
H. LEIGHTON GRIMES的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('H. LEIGHTON GRIMES', 18)}}的其他基金
A generalizable framework for linking single-cell genomic states with cell fate outcomes in hematopoiesis
将单细胞基因组状态与造血细胞命运结果联系起来的通用框架
- 批准号:
10410480 - 财政年份:2020
- 资助金额:
$ 39万 - 项目类别:
A generalizable framework for linking single-cell genomic states with cell fate outcomes in hematopoiesis
将单细胞基因组状态与造血细胞命运结果联系起来的通用框架
- 批准号:
10237929 - 财政年份:2020
- 资助金额:
$ 39万 - 项目类别:
A generalizable framework for linking single-cell genomic states with cell fate outcomes in hematopoiesis
将单细胞基因组状态与造血细胞命运结果联系起来的通用框架
- 批准号:
10645197 - 财政年份:2020
- 资助金额:
$ 39万 - 项目类别:
相似国自然基金
蛋白质降解决定因子的生物信息学筛选及其耐药突变的多组学分析研究
- 批准号:32300528
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于生物信息学的类风湿性关节炎患者衰弱预测模型的构建与验证
- 批准号:82301786
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于结构表征的蛋白质与长链非编码RNA相互作用预测的生物信息学方法研究
- 批准号:62373216
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
突变和修饰重塑蛋白质亚细胞定位的生物信息学研究
- 批准号:32370698
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
自身免疫性疾病精准诊疗中基于非编码RNA组学和生物信息学的新方法研究
- 批准号:82371855
- 批准年份:2023
- 资助金额:74 万元
- 项目类别:面上项目
相似海外基金
p16INK4a+ fibroblasts regulate epithelial regeneration after injury in lung alveoli through the SASP
p16INK4a成纤维细胞通过SASP调节肺泡损伤后的上皮再生
- 批准号:
10643269 - 财政年份:2023
- 资助金额:
$ 39万 - 项目类别:
Activity-Dependent Regulation of CaMKII and Synaptic Plasticity
CaMKII 和突触可塑性的活动依赖性调节
- 批准号:
10817516 - 财政年份:2023
- 资助金额:
$ 39万 - 项目类别: